drugset

drugset / Trial / NCT06045156

Early Tirofiban Administration After Intravenous Thrombolysis in Acute Ischemic Stroke

NCT06045156 ↗

Recruiting 1084 enrolled The First Hospital of Jilin University

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy and safety of early tirofiban administration in patients undergoing IVT

Timeline

Start: 2024-04-29
Primary completion: 2026-01-30
Completion: 2026-12-30

Publications

Guo ZN, Zhang KJ, Zhang P, Qu Y, Abuduxukuer R, Nguyen TN, Chen HS, Yang Y. Early tirofiban administration after intravenous thrombolysis in acute ischemic stroke (ADVENT): Study protocol of a multicenter, randomized, double-blind, placebo-controlled clinical trial. Eur Stroke J. 2024 Jun;9(2):510-514. doi: 10.1177/23969873231225069. Epub 2024 Jan 9.

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Tirofiban	Other / unclassified	0.1 ug/kg	—

Indications